Skip to main content
. 2020 Dec 16;8(4):770. doi: 10.3390/vaccines8040770

Table 2.

Study characteristics associated with adequate reporting.

Characteristic Categories Used for the Characteristic Crude Odds Ratio *
(95% CI)
p Value Adjusted Odds Ratio **
(95% CI)
p Value
Impact factor <10 Reference Reference
10 to 20 6.44
(1.24 to 33.58)
0.027 9.4
(1.30 to 67.83)
0.026
>20 4.29
(1.01 to 18.20)
0.048 2.89
(0.30 to 27.80)
0.35
Type of Funding Industrial funding Reference Reference
Non-industrial funding 0.28
(0.12 to 0.65)
0.003 0.55
(0.18 to 1.67)
0.29
No funding 0.09
(0.023 to 0.33)
<0.001 0.23
(0.45 to 1.26)
0.09
Type of journal Non-CONSORT endorsing Reference Reference
CONSORT endorsing 2.33
(1.04 to 5.26)
0.041 1.85
(0.59 to 5.84)
0.28
Year of publication 1990–2000 Reference Reference
2001–2010 5.99
(0.67 to 54.04)
0.110 4.89
(0.38 to 62.45)
0.22
2011–2018 25.24
(3.23 to 197.22)
0.002 25.8
(2.25 to 297.20)
0.009
Continent of study Africa Reference Reference
Asia 0.44
(0.12 to 1.61)
0.218 1.45
(0.22 to 9.56)
0.69
Europe 0.52
(0.22 to 1.25)
0.144 0.65
(0.22 to 1.93)
0.44
North America
South America 1
(0.059 to 16.79)
1.000 0.24
(0.007 to 8.40)
0.43
Number of centers Single center Reference
Multiple centers 1.344
(0.64 to 2.81)
0.432

CI, confidence interval. The crude odds ratios (*) show the results from the bivariate logistic regression analyses, and adjusted odds ratios (**) show results from the multiple logistic regression analysis. The latter was performed on all variables in the model.